CapitalBio developed the platform for multi-target nucleic acid rapid detection. With the support of detection kits, it can be used in a wide range of fields, such as medical diagnosis, life science, food safety, agricultural product testing, animal husbandry, and aquatic products.

The platform combines microfluidic technology and isothermal amplification technology to enable samples detection within 50 minutes. The detector sends the received fluorescent signal to the computer, where the supporting software processes it and draws it into a a real-time curve. When the detection is complete, the result is automatically interpreted and displayed. More reading: microfluidic platform

Microfluidic Platform